Literature DB >> 9713062

Impaired motion sensitivity as a predictor of subsequent field loss in glaucoma suspects: the Roscommon Glaucoma Study.

J Wu1, M Coffey, A Reidy, R Wormald.   

Abstract

AIM: To determine if impaired motion sensitivity is a significant predictor of subsequent field loss in glaucoma suspects.
METHOD: A population based prospective study; a 5 year follow up of all glaucoma suspects who had been identified from a population based random sample survey in the west of Ireland. 78 glaucoma suspects whose visual field function was annually measured by Henson CFS 2000 and for whom data on family history of glaucoma, ocular status, and motion impairment had been recorded. Visual field loss was defined as Henson visual field survival score of 94 or less.
RESULTS: 18 people developed visual field loss in at least one eye. Motion impairment at baseline was associated with a 2-18 times greater risk of development of the visual field loss (p < 0.001). This association was independent of sex, family history of glaucoma, intraocular pressure, and C/D ratio at baseline. The Cox's proportional hazards regression analysis confirmed the above results after adjustment for age and the C/D ratio.
CONCLUSION: Motion impairment is an independent predictor of visual field loss in glaucoma suspects, although it is not clear how long motion impairment precedes visual field loss.

Entities:  

Mesh:

Year:  1998        PMID: 9713062      PMCID: PMC1722580          DOI: 10.1136/bjo.82.5.534

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  18 in total

1.  High-tech advances in the treatment of chronic cancer pain.

Authors:  J Smith; R G Bulich; P B New
Journal:  Caring       Date:  1989-10

2.  Larger optic nerve heads have more nerve fibers in normal monkey eyes.

Authors:  H A Quigley; A L Coleman; M E Dorman-Pease
Journal:  Arch Ophthalmol       Date:  1991-10

3.  Motion perception is abnormal in primary open-angle glaucoma and ocular hypertension.

Authors:  S E Silverman; G L Trick; W M Hart
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-04       Impact factor: 4.799

4.  Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma.

Authors:  H A Quigley; G R Dunkelberger; W R Green
Journal:  Am J Ophthalmol       Date:  1989-05-15       Impact factor: 5.258

Review 5.  Visual field screening and the development of a new screening program.

Authors:  D B Henson
Journal:  J Am Optom Assoc       Date:  1989-12

6.  Optic disc morphometry in chronic primary open-angle glaucoma. II. Correlation of the intrapapillary morphometric data to visual field indices.

Authors:  J B Jonas; G C Gusek; G O Naumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

7.  Retinal ganglion cell classes in the Old World monkey: morphology and central projections.

Authors:  A G Leventhal; R W Rodieck; B Dreher
Journal:  Science       Date:  1981-09-04       Impact factor: 47.728

Review 8.  Psychophysical evidence for separate channels for the perception of form, color, movement, and depth.

Authors:  M S Livingstone; D H Hubel
Journal:  J Neurosci       Date:  1987-11       Impact factor: 6.167

9.  Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects.

Authors:  M F Armaly; D E Krueger; L Maunder; B Becker; J Hetherington; A E Kolker; R Z Levene; A E Maumenee; I P Pollack; R N Shaffer
Journal:  Arch Ophthalmol       Date:  1980-12

10.  Chronic glaucoma selectively damages large optic nerve fibers.

Authors:  H A Quigley; R M Sanchez; G R Dunkelberger; N L L'Hernault; T A Baginski
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-06       Impact factor: 4.799

View more
  1 in total

1.  Primary Open Angle Glaucoma Is Associated With Functional Brain Network Reorganization.

Authors:  Silvia Minosse; Francesco Garaci; Alessio Martucci; Simona Lanzafame; Francesca Di Giuliano; Eliseo Picchi; Massimo Cesareo; Raffaele Mancino; Maria Guerrisi; Chiara Adriana Pistolese; Roberto Floris; Carlo Nucci; Nicola Toschi
Journal:  Front Neurol       Date:  2019-10-25       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.